scispace - formally typeset
P

Prasenjit Mitra

Researcher at All India Institute of Medical Sciences

Publications -  49
Citations -  869

Prasenjit Mitra is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Blood lead level & Population. The author has an hindex of 8, co-authored 49 publications receiving 368 citations.

Papers
More filters
Journal ArticleDOI

Clinical and molecular aspects of lead toxicity: An update

TL;DR: The molecular basis of lead exposure resulting in various systemic effects is being extensively explored, and many genetic targets are identified, but their possible mechanisms are still an area to be explored.
Journal ArticleDOI

Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review.

TL;DR: In this paper, the authors conducted a systematic review of COVID-19 vaccine trials and found that most of the reactions reported were mild to moderate whereas a few with severe intensity.
Journal ArticleDOI

Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.

TL;DR: It is hypothesized that the ACE2 gene, encoding angiotensin-converting enzyme 2 (ACE2), is a genetic risk factor for SARS-CoV-2 infection and is required by the virus to enter cells.
Journal ArticleDOI

Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey.

TL;DR: This study included 725 patients from an Isolation center, of which 230 were excluded due to reasons like incorrect phone numbers, no response on phone, or denying consent to participate, and there were no reported acute or severe adverse effects with these products.
Journal ArticleDOI

Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review

TL;DR: The aim of this review is to provide an update on the general characteristics of SARS-CoV-2 and highlight the inflammatory changes and immune dysregulation that may help in identification of molecular predictors of disease severity.